Krishana Phoschem Limited has informed the Exchange about Transcript
KRISHANA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Krishana Phoschem reported a strong Q4 FY25 with revenue of ₹472.9 crore (up 79.5% YoY), EBITDA of ₹56.3 crore (up 119.2% YoY) at 11.9% margin, and PAT of ₹32.6 crore (up 492.7% YoY). For full-year FY25, revenue grew 47% to ₹1,358.2 crore, EBITDA rose 43.4% to ₹183.9 crore (13.5% margin), and PAT more than doubled to ₹86.3 crore. Volumes grew 50% versus industry growth of 7.5%, with SSP sales of 1.17 lakh tons and NPK/DAP sales of 2.33 lakh tons. Management guided FY26 NPK volumes of ~2.8 lakh tons, capacity utilization improving from 70% to 80%, and stable EBITDA margins around 12%. Net debt declined 19% YoY, and the company is in advanced stages of capacity expansion including inorganic acquisition plans.
Positive for shareholders — record volumes, margin stability, and debt reduction signal operational strength. Acquisition plans and capacity expansion could drive future growth, though CFO avoided commenting on a potential QIP, leaving fundraising timeline unclear.